EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives

Alexander Panossian iD, Terry Lemerond, Thomas Efferth iD

Pharmaceuticals · 10.04.2024 · 17 (4) · 483

DOI: 10.3390/ph17040483 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.04.2024. Verfasst von Alexander Panossian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Phytomed AB, Sjöstadsvägen 6A, Lgh 1004, 59344 Västervik, Sweden. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite some evidence supporting the synergy concept, the commonly known assumption that combinations of several herbs in one formulation can have better efficacy due to additive or synergistic effects has yet to be unambiguously and explicitly studied. Study aim: The study aimed to reveal the molecular interactions in situ of host cells in response to botanical hybrid preparations (BHP) intervention and justify the benefits of implementing BHP in clinical practice.

Results

This prospective literature review provides the results of recent clinical and network pharmacology studies of BHP of Rhodiola rosea L. (Arctic root) with other plants, including Withania somnifera (L.) Dunal (ashwagandha), (Camellia sinensis (L.) Kuntze (green tea), Eleutherococcus senticosus (Rupr. and Maxim.) Maxim. (eleuthero), Schisandra chinensis (Turcz.) Baill. (schisandra), Leuzea carthamoides (Willd.) DC., caffeine, Cordyceps militaris L., Ginkgo biloba L.(ginkgo), Actaea racemosa L. (black cohosh), Crocus sativus L. (saffron), and L-carnosine.

Conclusions

The most important finding from network pharmacology studies of BHP was the evidence supporting the synergistic interaction of BHP ingredients, revealing unexpected new pharmacological activities unique and specific to the new BHP. Some studies show the superior efficacy of BHP compared to mono-drugs. At the same time, some a priori-designed combinations can fail, presumably due to antagonistic interactions and crosstalk between molecular targets within the molecular networks involved in the cellular and overall response of organisms to the intervention. Network pharmacology studies help predict the results of studies aimed at discovering new indications and unpredicted adverse events.

Schlagwörter

Stichwörter der Autor:innen

Rhodiola rosea clinical trialsbotanical hybrid preparationsgene expressionnetwork pharmacologysynergy

Autor:innen und Institutionen

  • Phytomed AB, Sjöstadsvägen 6A, Lgh 1004, 59344 Västervik, Sweden.
  • EuroPharma USA Inc., Green Bay, WI 54311, USA.
  • Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, 55099 Mainz, Germany.

ORCID-Profile: Alexander Panossian, Thomas Efferth

Zitieren

APA

Panossian, A., Lemerond, T., & Efferth, T. (2024). State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives. Pharmaceuticals, 17(4), 483. https://doi.org/10.3390/ph17040483

Vancouver

Panossian A, Lemerond T, Efferth T. State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives. Pharmaceuticals. 2024;17(4):483. doi:10.3390/ph17040483

BibTeX
@article{Panossian2024,
  author = {Panossian, Alexander and Lemerond, Terry and Efferth, Thomas},
  title = {State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {4},
  pages = {483},
  doi = {10.3390/ph17040483}
}
Kostenlos starten →